ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill

September 27, 1996

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

ACS Announces New Awards for Nurses

October 30, 1987

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993